Janus Henderson Group PLC Janux Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,460,332 shares of JANX stock, worth $108 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,460,332

Previous 4,598,092 3.0%

Holding current value

$108 Million

Previous $124 Million 17.01%

% of portfolio

0.05%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$22.62 - $33.2 $3.12 Million - $4.57 Million	-137,760 Reduced 3.0%	4,460,332 $103 Million
Q1 2025 May 15, 2025	BUY	$27.0 - $57.81 $28 Million - $59.9 Million	1,035,690 Added 29.07%	4,598,092 $124 Million
Q4 2024 Feb 14, 2025	BUY	$40.18 - $66.83 $41.7 Million - $69.4 Million	1,038,996 Added 41.17%	3,562,402 $191 Million
Q3 2024 Nov 14, 2024	BUY	$35.29 - $50.26 $25.5 Million - $36.3 Million	721,563 Added 40.05%	2,523,406 $115 Million
Q2 2024 Aug 14, 2024	SELL	$35.12 - $64.78 $5.75 Million - $10.6 Million	-163,703 Reduced 8.33%	1,801,843 $75.5 Million
Q1 2024 May 15, 2024	BUY	$7.93 - $49.75 $270,167 - $1.69 Million	34,069 Added 1.76%	1,965,546 $74 Million
Q4 2023 Feb 14, 2024	SELL	$5.85 - $11.7 $795,547 - $1.59 Million	-135,991 Reduced 6.58%	1,931,477 $20.7 Million
Q3 2023 Nov 14, 2023	SELL	$9.56 - $14.0 $400,277 - $586,180	-41,870 Reduced 1.98%	2,067,468 $20.8 Million
Q2 2023 Aug 14, 2023	BUY	$11.08 - $15.92 $2.66 Million - $3.82 Million	240,262 Added 12.85%	2,109,338 $25 Million
Q1 2023 May 15, 2023	BUY	$11.25 - $22.21 $351,956 - $694,839	31,285 Added 1.7%	1,869,076 $22.6 Million
Q4 2022 Feb 14, 2023	SELL	$11.1 - $18.26 $1.36 Million - $2.23 Million	-122,253 Reduced 6.24%	1,837,791 $24.2 Million
Q3 2022 Nov 14, 2022	SELL	$10.82 - $16.84 $1.82 Million - $2.82 Million	-167,753 Reduced 7.88%	1,960,044 $26.5 Million
Q2 2022 Aug 15, 2022	SELL	$9.52 - $15.65 $2.01 Million - $3.31 Million	-211,349 Reduced 9.04%	2,127,797 $26 Million
Q1 2022 May 16, 2022	SELL	$13.24 - $20.24 $817,530 - $1.25 Million	-61,747 Reduced 2.57%	2,339,146 $33.5 Million
Q4 2021 Feb 14, 2022	SELL	$15.44 - $27.32 $239,489 - $423,760	-15,511 Reduced 0.64%	2,400,893 $46.6 Million
Q3 2021 Nov 16, 2021	SELL	$20.7 - $34.69 $5.21 Million - $8.74 Million	-251,803 Reduced 9.44%	2,416,404 $51.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.58 - $25.37 $49.6 Million - $67.7 Million	2,668,207 New	2,668,207 $64.5 Million

Others Institutions Holding JANX

# of Institutions

186

Shares Held

55.9M

Call Options Held

869K

Put Options Held

652K

View Full List

About Janux Therapeutics, Inc.

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $1.01B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

More about JANX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Janux Therapeutics, Inc. Transaction History